Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Inhaled Nitric Oxide (iNO) use

ApprovedSmall molecule

TThe University of Texas Health Science Center, Houston

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q2 2031

Post-ApprovalRecruiting

Hernia

NCT05213676

Clinical

Trials by Indication[1]

Hernia1 trial

De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia

Recruiting·TThe University of Texas Health Science Center, Houston·Phase 4·NCT05213676·600 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Inhaled Nitric Oxide (iNO) use. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Inhaled Nitric Oxide (iNO) use compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Inhaled Nitric Oxide (iNO) use. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — The University of Texas Health Science Center, Houston company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: TThe University of Texas Health Science Center, Houston

Related News